12481161

Source:http://linkedlifedata.com/resource/pubmed/id/12481161

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0013295, umls-concept:C0028978, umls-concept:C0087111, umls-concept:C0205177, umls-concept:C0378482
pubmed:issue	3
pubmed:dateCreated	2002-12-13
pubmed:abstractText	Rabeprazole has been demonstrated to be a potent antisecretory agent and has been shown to be clinically effective in the treatment of acid-related diseases.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0150472
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/2-Pyridinylmethylsulfinylbenzimidazo..., http://linkedlifedata.com/resource/pubmed/chemical/Amoxicillin, http://linkedlifedata.com/resource/pubmed/chemical/Anti-Ulcer Agents, http://linkedlifedata.com/resource/pubmed/chemical/Benzimidazoles, http://linkedlifedata.com/resource/pubmed/chemical/Clarithromycin, http://linkedlifedata.com/resource/pubmed/chemical/Omeprazole, http://linkedlifedata.com/resource/pubmed/chemical/Proton-Translocating ATPases, http://linkedlifedata.com/resource/pubmed/chemical/rabeprazole
pubmed:status	MEDLINE
pubmed:issn	0012-2823
pubmed:author	pubmed-author:BentivegnaCC, pubmed-author:BranciforteGG, pubmed-author:BrognaAA, pubmed-author:CatalanoFF, pubmed-author:ScaliaAA, pubmed-author:TerminellaCC
pubmed:copyrightInfo	Copyright 2002 S. Karger AG, Basel
pubmed:issnType	Print
pubmed:volume	66
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	154-9
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:12481161-2-Pyridinylmethylsulfinylbenzimidazoles, pubmed-meshheading:12481161-Adult, pubmed-meshheading:12481161-Amoxicillin, pubmed-meshheading:12481161-Anti-Ulcer Agents, pubmed-meshheading:12481161-Benzimidazoles, pubmed-meshheading:12481161-Clarithromycin, pubmed-meshheading:12481161-Drug Administration Schedule, pubmed-meshheading:12481161-Drug Therapy, Combination, pubmed-meshheading:12481161-Duodenal Ulcer, pubmed-meshheading:12481161-Female, pubmed-meshheading:12481161-Helicobacter Infections, pubmed-meshheading:12481161-Helicobacter pylori, pubmed-meshheading:12481161-Humans, pubmed-meshheading:12481161-Male, pubmed-meshheading:12481161-Omeprazole, pubmed-meshheading:12481161-Patient Compliance, pubmed-meshheading:12481161-Prospective Studies, pubmed-meshheading:12481161-Proton-Translocating ATPases
pubmed:year	2002
pubmed:articleTitle	Eradication therapy with rabeprazole versus omeprazole in the treatment of active duodenal ulcer.
pubmed:affiliation	Gastroenterology and Digestive Endoscopy Service, University of Catania, Garibaldi Hospital, Catania, Italy. f.catalano@mbox.unict.it
pubmed:publicationType	Journal Article, Clinical Trial, Randomized Controlled Trial